Portfolio

Portocanna, S.A.
Medical Canábis
EGF II | EGF III

Invested in
2023

Investment Rationale

Portocanna aims to be one of the main medical-pharmaceutical cannabis processors in Europe.

 Strategy

Development of new pharmaceutical formulas applicable to the processing of cannabis plant and oil under EU-GMP conditions.